AFT Pharmaceuticals Limited (ASX:AFP)

Australia flag Australia · Delayed Price · Currency is AUD
2.300
0.00 (0.00%)
Sep 1, 2025, 11:50 AM AEST
Market Cap248.05M
Revenue (ttm)189.03M
Net Income (ttm)10.87M
Shares Outn/a
EPS (ttm)0.10
PE Ratio22.82
Forward PE16.89
Dividend0.02 (0.73%)
Ex-Dividend DateJun 18, 2025
Volume2,000
Average Volume1,110
Open2.300
Previous Close2.300
Day's Range2.300 - 2.300
52-Week Range2.150 - 3.160
Beta0.36
RSI41.86
Earnings DateAug 21, 2025

About AFT Pharmaceuticals

AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital. It has a research and development collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injecta... [Read more]

Sector Healthcare
Founded 1997
Employees 119
Stock Exchange Australian Securities Exchange
Ticker Symbol AFP
Full Company Profile

Financial Performance

In 2024, AFT Pharmaceuticals's revenue was 208.02 million, an increase of 6.45% compared to the previous year's 195.41 million. Earnings were 11.96 million, a decrease of -23.36%.

Financial numbers in NZD Financial Statements

News

There is no news available yet.